GBS Clinical Trial
Study hypothesis: Intrapartum polimeraze chain reaction (PCR)of group B streptoccocus (GBS)
test is more accurate than Culture of GBS at 35-37 weeks gestation for GBS carriage.
The investigators will compare GBS culture and PCR results taken at 35-37 weeks gestation to
intrapartum PCR GBS and GBS cultures status.
The larger perspective of this trial is to check the possibility of replacing the GBS
culture screening program at 35-37 weeks gestation with a more accurate examination (PCR),
avoiding the changing GBS carriage status from the time of culture at 35-37 weeks to
delivery.
n/a
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT04116645 -
Time Frame for GBS Screening
|
||
| Completed |
NCT02497430 -
Clinical Evaluation of the ARIES Group B Streptococcus (GBS) Assay
|
N/A | |
| Completed |
NCT03936816 -
The Implementation of Real-time PCR - Intrapartum GBS (Group B Streptococcus) Colonization to Reduce Antibiotic Prophylaxis
|
||
| Completed |
NCT03008421 -
Oral Probiotics to Reduce Vaginal Group B Streptococcal Colonization in Late Pregnancy
|
N/A | |
| Not yet recruiting |
NCT03064672 -
Transcervical Balloon Catheters in GBS Carriers, Is It Safe? A Randomized Controlled Trial
|
N/A | |
| Completed |
NCT02883270 -
Effects of Robotic-assisted Gait Training In Non-Ambulatory Patients After Guillain-Barré Syndrome
|
N/A | |
| Completed |
NCT04434391 -
QF-PCR In GBS Diagnosis During Pregnancy
|
||
| Recruiting |
NCT04871035 -
Immunoadsorption Versus Plasma Exchange for Treatment of Guillain-Barré Syndrome (GBS)
|